查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1579335

愛迪生氏症檢測市場：按產品、檢測類型、樣本類型和最終用戶分類 - 全球預測 2025-2030

Addison's Disease Testing Market by Offering (Consumables, Instruments & Devices, Software & Services), Test Type (Autoantibody Tests, Biochemical Tests, Imaging Tests), Sample Type, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，愛迪生氏症檢測市值為2.5702億美元，預計到2024年將達到2.6669億美元，複合年成長率為3.91%，到2030年將達到3.3641億美元。

愛迪生氏症檢查篩檢腎上腺功能不全，這是一種以腎上腺激素分泌不足為特徵的疾病。這項測試非常重要，因為它有助於及時診斷和治療愛迪生氏症，並可以預防腎上腺危像等潛在危及生命的疾病。對這些測試的需求源於該疾病的特異性症狀，這些症狀經常被誤認為是其他疾病，使得早期檢測變得困難，但至關重要。最終用途是醫療機構、研究機構和專科診所。市場洞察表明，人們對內分泌疾病的認知不斷提高、診斷技術的進步以及自體免疫疾病盛行率的上升正在推動這一成長。關鍵的成長要素包括快速和非侵入性檢測方法等技術創新、提高患者依從性和推動需求。此外，發展中地區醫療保健支出的增加帶來了新的成長途徑。最近的發展表明，數位醫療的進步促進了遠端醫療和遠距測試的潛在機會，從而允許進入滲透不足的市場。為了利用這些機會，公司應該投資開發具有成本效益的可攜式測試解決方案，並與數位健康平台合作以擴大其覆蓋範圍。然而，挑戰仍然存在，例如嚴格的監管合規性、與先進測試技術相關的高成本以及低收入地區的意識有限，這可能會阻礙市場擴張。解決這些限制需要策略夥伴關係、簡化監管和進行宣傳活動。促進業務成長的創新研究領域包括開發與人工智慧整合的就地檢驗設備，用於預測診斷和個人化治療計劃。愛迪生氏症檢測市場本質上受到醫療保健趨勢和技術進步的影響，因此處於研發前沿並利用與高科技公司的夥伴關係可以提高您的競爭力並確保業務的永續性。

主要市場統計
基準年[2023] 25702萬美元
預測年份 [2024] 26669萬美元
預測年份 [2030] 33641萬美元
複合年成長率（%） 3.91%

市場動態：快速發展的愛迪生氏症檢測市場的關鍵市場洞察

愛迪生氏症檢測市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 由於與愛迪生氏症相關的臨床試驗和研究活動增加，推動了檢測需求
    • 提供愛迪生氏症檢測優惠報銷政策以促進市場成長
    • 擴大新興國家的醫療基礎設施和診斷中心
    • 產業主要企業之間的協作和夥伴關係，以增強測試產品和市場覆蓋範圍
  • 市場限制因素
    • 監管障礙和漫長的核准流程減緩了先進測試技術的引入
    • 缺乏專門的診斷設施和訓練有素的專業人員會影響測試品質和患者結果
  • 市場機會
    • 對愛迪生氏症家庭診斷試劑套件的需求不斷成長
    • 支持罕見疾病研究和診斷的政府措施和資金
    • 透過擴大新興市場的醫療基礎設施來改善檢測機會
  • 市場挑戰
    • 愛迪生氏症診斷測試​​和治療的費用高昂且保險範圍有限
    • 缺乏標準化的測試通訊協定以及測試可用性的區域差異

波特五力：駕馭愛迪生氏症檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解愛迪生氏症檢測市場的外部影響

外部宏觀環境因素在塑造愛迪生氏症檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解愛迪生氏症檢測市場的競爭狀況

愛迪生氏症檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣愛迪生氏症檢測市場供應商的績效評估

FPNV 定位矩陣是評估愛迪生氏症檢測市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了愛迪生氏症檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對愛迪生氏症檢測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 與愛迪生氏症相關的臨床試驗和研究活動的增加增加了對檢測的需求。
      • 愛迪生氏症檢測的優惠報銷政策推動市場成長
      • 擴大新興國家的醫療基礎設施和診斷中心
      • 主要行業參與者之間的合作和夥伴關係增強了測試交付和市場覆蓋範圍
    • 抑制因素
      • 監管障礙和漫長的核准流程減緩了先進測試技術的引入
      • 缺乏專門的診斷設施和訓練有素的專業人員會影響測試品質和患者結果
    • 機會
      • 對愛迪生氏症家庭診斷試劑套件的需求增加
      • 支持罕見疾病研究和診斷的政府措施和資金
      • 擴大新興市場的醫療保健基礎設施改善了檢測的機會
    • 任務
      • 愛迪生氏症的診斷檢查和治療費用昂貴，而且保險範圍有限。
      • 缺乏標準化的測試通訊協定以及不同地區的測試可用性不同
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章愛迪生氏症檢測市場：透過提供

  • 消耗品
    • 試劑
    • 檢測套組
  • 設備和裝置
    • 血液分析儀
    • CT掃描儀
    • 核磁共振造影系統
  • 軟體和服務

第7章愛迪生氏症檢測市場（按檢測類型）

  • 自體抗體測試
  • 生物化學檢驗
    • ACTH興奮試驗
    • 基準皮質醇測試
    • 電解質板
    • 腎素-醛固酮比值
    • 血清ACTH測試
  • 影像檢查

第8章愛迪生氏症檢測市場（按樣本類型）

  • 驗血
  • 唾液測試
  • 尿液檢查

第 9 章愛迪生氏症檢測市場：依最終用途分類

  • 醫院/臨床實驗室
  • 門診

第10章 美洲愛迪生氏症檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區愛迪生氏症檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲愛迪生氏症檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abcam Limited
  • ARUP Laboratories
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Max Lab
  • Merck KGaA
  • Metropolis Healthcare
  • Myriad Genetics, Inc.
  • Quest Diagnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-B53D3ECDDA3A

The Addison's Disease Testing Market was valued at USD 257.02 million in 2023, expected to reach USD 266.69 million in 2024, and is projected to grow at a CAGR of 3.91%, to USD 336.41 million by 2030.

Addison's Disease Testing involves screening for adrenal insufficiency, a condition characterized by inadequate production of adrenal hormones. This testing is critical as it helps in the timely diagnosis and management of Addison's Disease, thus preventing potential life-threatening situations such as adrenal crisis. The necessity of these tests stems from the disease's non-specific symptoms, often mistaken for other ailments, making early detection challenging yet crucial. Applications primarily lie in endocrinology and diagnostic laboratories, while end-use comprises healthcare facilities, research institutes, and specialty clinics. Market insights indicate growth driven by increasing awareness of endocrine disorders, advancements in diagnostic technologies, and a rising prevalence of autoimmune diseases. Key growth factors include technological innovations such as rapid and non-invasive testing methods, which enhance patient compliance and boost demand. Moreover, increased healthcare expenditure in developing regions presents new growth avenues. Recent trends suggest a potential opportunity in telemedicine and remote testing facilitated by digital health advancements, enabling access to underpenetrated markets. To capitalize on these opportunities, businesses should invest in developing cost-effective, portable testing solutions and collaborate with digital health platforms to expand their reach. However, challenges persist, such as stringent regulatory compliances, high costs associated with advanced testing technologies, and limited awareness in low-income regions, which could hinder market expansion. Addressing these limitations requires strategic partnerships, regulatory streamlining, and awareness campaigns. Innovative research areas for business growth include developing point-of-care testing devices integrated with AI for predictive diagnostics and personalized treatment plans. As the market for Addison's Disease Testing is inherently influenced by healthcare trends and technological advancements, staying at the forefront of R&D and leveraging partnerships with tech companies can offer a competitive edge, ensuring sustained business growth and market relevance.

KEY MARKET STATISTICS
Base Year [2023] USD 257.02 million
Estimated Year [2024] USD 266.69 million
Forecast Year [2030] USD 336.41 million
CAGR (%) 3.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Addison's Disease Testing Market

The Addison's Disease Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of clinical trials and research activities on Addison's disease driving demand for testing
    • Availability of favorable reimbursement policies for Addison's disease testing boosting market growth
    • Expansion of healthcare infrastructure and diagnostic centers in emerging economies
    • Collaborations and partnerships among key industry players to enhance test offerings and market reach
  • Market Restraints
    • Regulatory hurdles and lengthy approval processes delaying the introduction of advanced testing technologies
    • Shortage of specialized diagnostic facilities and trained professionals impacting the quality of testing and patient outcomes
  • Market Opportunities
    • Rising demand for home-based diagnostic kits for Addison's disease
    • Government initiatives and funding supporting rare disease research and diagnostics
    • Expansion of healthcare infrastructure in emerging markets boosting testing accessibility
  • Market Challenges
    • High cost and limited insurance coverage for Addison's disease diagnostic tests and treatments
    • Lack of standardized testing protocols and variability in testing availability across different regions

Porter's Five Forces: A Strategic Tool for Navigating the Addison's Disease Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Addison's Disease Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Addison's Disease Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Addison's Disease Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Addison's Disease Testing Market

A detailed market share analysis in the Addison's Disease Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Addison's Disease Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Addison's Disease Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Addison's Disease Testing Market

A strategic analysis of the Addison's Disease Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Addison's Disease Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Limited, ARUP Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hologic, Inc., Max Lab, Merck KGaA, Metropolis Healthcare, Myriad Genetics, Inc., Quest Diagnostics, Quidel Corporation, Randox Laboratories Ltd., Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Addison's Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Consumables, Instruments & Devices, and Software & Services. The Consumables is further studied across Reagents and Test Kits. The Instruments & Devices is further studied across Blood Analyzers, CT Scanners, and MRI Machines.
  • Based on Test Type, market is studied across Autoantibody Tests, Biochemical Tests, and Imaging Tests. The Biochemical Tests is further studied across ACTH Stimulation Test, Baseline Cortisol Test, Electrolyte Panel, Renin-Aldosterone Ratio, and Serum ACTH Test.
  • Based on Sample Type, market is studied across Blood Tests, Saliva Tests, and Urine Tests.
  • Based on End-Use, market is studied across Hospital/Clinical Laboratory and Outpatient Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of clinical trials and research activities on Addison's disease driving demand for testing
      • 5.1.1.2. Availability of favorable reimbursement policies for Addison's disease testing boosting market growth
      • 5.1.1.3. Expansion of healthcare infrastructure and diagnostic centers in emerging economies
      • 5.1.1.4. Collaborations and partnerships among key industry players to enhance test offerings and market reach
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory hurdles and lengthy approval processes delaying the introduction of advanced testing technologies
      • 5.1.2.2. Shortage of specialized diagnostic facilities and trained professionals impacting the quality of testing and patient outcomes
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for home-based diagnostic kits for Addison's disease
      • 5.1.3.2. Government initiatives and funding supporting rare disease research and diagnostics
      • 5.1.3.3. Expansion of healthcare infrastructure in emerging markets boosting testing accessibility
    • 5.1.4. Challenges
      • 5.1.4.1. High cost and limited insurance coverage for Addison's disease diagnostic tests and treatments
      • 5.1.4.2. Lack of standardized testing protocols and variability in testing availability across different regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Addison's Disease Testing Market, by Offering

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Reagents
    • 6.2.2. Test Kits
  • 6.3. Instruments & Devices
    • 6.3.1. Blood Analyzers
    • 6.3.2. CT Scanners
    • 6.3.3. MRI Machines
  • 6.4. Software & Services

7. Addison's Disease Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Autoantibody Tests
  • 7.3. Biochemical Tests
    • 7.3.1. ACTH Stimulation Test
    • 7.3.2. Baseline Cortisol Test
    • 7.3.3. Electrolyte Panel
    • 7.3.4. Renin-Aldosterone Ratio
    • 7.3.5. Serum ACTH Test
  • 7.4. Imaging Tests

8. Addison's Disease Testing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Tests
  • 8.3. Saliva Tests
  • 8.4. Urine Tests

9. Addison's Disease Testing Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospital/Clinical Laboratory
  • 9.3. Outpatient Clinics

10. Americas Addison's Disease Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Addison's Disease Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Addison's Disease Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam Limited
  • 3. ARUP Laboratories
  • 4. Beckman Coulter, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Danaher Corporation
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche Ltd
  • 10. Hologic, Inc.
  • 11. Max Lab
  • 12. Merck KGaA
  • 13. Metropolis Healthcare
  • 14. Myriad Genetics, Inc.
  • 15. Quest Diagnostics
  • 16. Quidel Corporation
  • 17. Randox Laboratories Ltd.
  • 18. Siemens Healthineers
  • 19. Sysmex Corporation
  • 20. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ADDISON'S DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ADDISON'S DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ADDISON'S DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ADDISON'S DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ADDISON'S DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ADDISON'S DISEASE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AUTOANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ACTH STIMULATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BASELINE CORTISOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY RENIN-ALDOSTERONE RATIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SERUM ACTH TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITAL/CLINICAL LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 326. ADDISON'S DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 327. ADDISON'S DISEASE TESTIN